Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients

Clinical trial NCT01131364 · TERMINATED

Trial details

NCT number: NCT01131364
Sponsor: Philogen S.p.A.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Breast Cancer

Start date: 2008-06-01
Primary completion: 2012-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.